Bear in mind operation costs and R&D funding will rise significantly you would think. One thing I do find hard to reconcile is the enormous difference between what Anteris is operating on compared to their Competitors, 100 million US dollars is fractions of what the Competitors spend per year.
is anybody aware of what the Company will be allowed to raise each year in the States?, CRs could likely be yearly once the original funding is exhausted.
Ann: Plan to Pursue Re-domiciliation, Nasdaq listing and US IPO, page-49
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.22 |
Change
0.740(6.45%) |
Mkt cap ! $258.3M | |||
| Open | High | Low | Value | Volume |
| $11.50 | $12.25 | $11.49 | $395.2K | 33.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $11.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.22 | 127 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |